Home Cart Sign in  
Chemical Structure| 1799633-27-4 Chemical Structure| 1799633-27-4

Structure of S63845
CAS No.: 1799633-27-4

Chemical Structure| 1799633-27-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

S63845 stands out as a potent and selective inhibitor of myeloid cell leukemia 1 (MCL1), featuring a Kd of 0.19 nM for human MCL1.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of S63845

CAS No. :1799633-27-4
Formula : C39H37ClF4N6O6S
M.W : 829.26
SMILES Code : O=C(O)[C@@H](OC1=C(C(C2=CC=C(OCCN3CCN(C)CC3)C(Cl)=C2C)=C(C4=CC=C(F)O4)S5)C5=NC=N1)CC6=CC=CC=C6OCC7=CC=NN7CC(F)(F)F
MDL No. :MFCD31382374

Safety of S63845

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
DKO ERCs 10 μM 48 hours To assess the effect of S63845 on the viability of DKO ERCs, results showed a significant decrease in cell viability PMC7774262
Mdr2−/− ERCs 10 μM 48 hours To assess the effect of S63845 on the viability of Mdr2−/− ERCs, results showed a significant decrease in cell viability PMC7774262
603B cholangiocytes 10 μM 24 hours To assess the effect of S63845 on apoptosis in TWEAK-treated 603B cholangiocytes, results showed a significant increase in apoptosis PMC7774262
AML cell lines 50nM 16 hours Dynamic BH3 profiling assessed the effect of S63845 on AML cell lines, showing increased BCL-2 dependence. PMC7988687
HCT116 cells 5 μM 72 hours S63845 restored the sensitivity of HCT116 cells to regorafenib by inducing apoptosis. PMC7381732
SW837 cells 5 μM 72 hours S63845 restored the sensitivity of SW837 cells to regorafenib by inducing apoptosis. PMC7381732
SW48 cells 5 μM 72 hours S63845 restored the sensitivity of SW48 cells to regorafenib by inducing apoptosis. PMC7381732
LoVo cells 5 μM 72 hours S63845 restored the sensitivity of LoVo cells to regorafenib by inducing apoptosis. PMC7381732
HCT-8 cells 5 μM 72 hours S63845 restored the sensitivity of HCT-8 cells to regorafenib by inducing apoptosis. PMC7381732
LS411N cells 5 μM 72 hours S63845 restored the sensitivity of LS411N cells to regorafenib by inducing apoptosis. PMC7381732
μMTV-PyMT cells 1 μM 24 hours In 2D culture, S63845 alone failed to significantly affect cell viability. PMC8408186
MDA-MB-231 cells 1 μM 7 days In tumoursphere assay, MDA-MB-231 cells were highly sensitive to S63845, and MCL1-deficient cells were unable to form tumourspheres. PMC8408186
BCP-ALL cell lines 2.5, 5, 25, 50, 250, 500, 2500 nM 48 hours To evaluate the cell death induction effect of S63845 on different BCP-ALL cell lines, heterogeneous sensitivity to S63845 was found among the cell lines. PMC8979822
BCP-ALL PDX samples 1, 5, 10, 50, 100, 250, 500 nM, 1, 5, 10 µM 24 hours To evaluate the cell death induction effect of S63845 on BCP-ALL PDX samples, sensitivity to S63845 was observed in some samples. PMC8979822
A549 cells 3 μM 4 hours To study the effect of S63845 on N protein-mediated apoptosis inhibition, results showed that S63845 eliminated the apoptosis inhibition by N protein. PMC10169150
THP-1 cells 3 μM 4 hours To study the effect of S63845 on N protein-mediated apoptosis inhibition, results showed that S63845 eliminated the apoptosis inhibition by N protein. PMC10169150
U937 cells 20 nM 24 hours Induced apoptosis, synergistically increased cell death with SKI-606 PMC11808118
MV4-11 cells 2 nM 24 hours Synergistically induced apoptosis PMC11808118

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Mdr2−/− and DKO mice Tail vein injection 200 mg/kg/d Once daily for 16 weeks To assess the effect of S63845 on hepatic fibrosis in Mdr2?/? and DKO mice, results showed that S63845 significantly reduced the DR-cell population and attenuated hepatic fibrosis PMC7774262
Mice AML PDX models Intravenous injection 0.3–0.9 g/l For more than 3 weeks Evaluated the anti-leukemic activity of S63845 in AML PDX models, showing significant reduction in leukemic burden in some models. PMC7988687
nude mice HCT116 xenograft tumor model intraperitoneal injection 40 mg/kg Once daily for 5 days S63845 restored the sensitivity of HCT116 xenograft tumors to regorafenib by inducing apoptosis. PMC7381732
Mice MMTV-PyMT mammary tumour model Intravenous injection 25 mg/kg Twice a week, continuous treatment S63845 significantly impeded the growth of MMTV-PyMT tumours, reducing post-treatment tumour weight to around one third. PMC8408186
NOD/SCID mice patient-derived xenograft model intraperitoneally 20 mg/kg once daily for 4 days To evaluate the anti-leukemia activity of S63845 in combination with venetoclax in vivo, the combination treatment significantly enhanced anti-leukemia activity. PMC8979822
C57BL/6 mice AAV-Lung-N C57BL/6 mice intraperitoneal injection 25 mg/kg Twice weekly for 3 weeks To study the effect of S63845 on N protein-mediated apoptosis inhibition, results showed that S63845 restored the apoptosis inhibition by N protein. PMC10169150
Mice HIV-1 infection model Intravenous injection 25 mg/kg/d once daily for two weeks (days 1-5) To evaluate the effect of S63845 alone on viral rebound in HIV-1 infected mice. Results showed that S63845 alone did not significantly delay viral rebound. PMC10518630
Mice U937 cell xenograft model Intraperitoneal injection 12.5 mg/kg repeated treatment on the fourth day after infection Significantly reduced tumor volume and weight, prolonged survival PMC11808118

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.21mL

0.24mL

0.12mL

6.03mL

1.21mL

0.60mL

12.06mL

2.41mL

1.21mL

References

 

Historical Records

Categories